Clinical Trials Browser

Interventional × margetuximab × Gastrointestinal × Clear all

NCT04082364 2025-06-08

MAHOGANY

Phase 2/3 Completed

82 enrolled 22 charts

Gastrointestinal

Stomach Neoplasms

NCT02689284 2025-03-17

Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer

Phase 1/2 Completed

95 enrolled 26 charts

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT01148849 2025-02-26

Safety Study of MGAH22 in HER2-positive Carcinomas

Phase 1 Completed

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms